Eptifibatide: Clinical Trials

8 trials of Eptifibatide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 5, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Eptifibatide: new trials by email Literature Review of Eptifibatide trials Research Report on Eptifibatide

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis
Eptifibatide (Integrilin), Standard Medical Therapy - Acute Ischemic Stroke
Phase 3Not yet recruitingXinqiao Hospital of Chongqing7862026-03-012026-01-16
Multi-arm Optimization of Stroke Thrombolysis
Argatroban, Eptifibatide, Placebo - Acute Ischemic Stroke
Phase 3CompletedWashington University School of Medicine5142019-10-152025-02-07
Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
Eptifibatide Injection - Acute Ischemic Stroke
Phase 3UnknownMinistry of Science and Technology of the People´s Republic of China2202019-04-062019-06-18
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
Otamixaban, Placebo (for Otamixaban), UFH - Acute Coronary Syndrome
Phase 3CompletedSanofi132202010-04-012016-05-04
INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial
eptifibatide, placebo - Cardiovascular Disease
Phase 3CompletedFondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS912007-11-012010-05-28
Eptifibatide and ST Segment Resolution Following Primary PCI
eptifibitide - Myocardial Infarction
Phase 3TerminatedMedstar Health Research Institute222007-08-012014-08-11
Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)
Abciximab, Eptifibatide - Infarction, Myocardial
Phase 3CompletedGlaxoSmithKline4292006-10-012012-11-27
EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
Eptifibatide (Integrilin), Placebo - Myocardial Ischemia, Acute Coronary Syndrome
Phase 3CompletedOrganon and Co94062004-11-012024-05-17

Conditions studied

Ischemic Stroke (3)  ·  Myocardial Infarction (3)  ·  Acute Coronary Syndrome (2)  ·  Cardiovascular Diseases (2)  ·  ST Elevation Myocardial Infarction (2)  ·  Angina Pectoris (1)  ·  Coronary Artery Disease (1)  ·  Ischemia (1)  ·  Myocardial Ischemia (1)

Sponsors

Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS (1)  ·  GlaxoSmithKline (1)  ·  Medstar Health Research Institute (1)  ·  Ministry of Science and Technology of the People´s Republic of China (1)  ·  Organon and Co (1)  ·  Sanofi (1)  ·  Washington University School of Medicine (1)  ·  Xinqiao Hospital of Chongqing (1)

Countries

United States (3)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belarus (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)

Top investigators

Daojun Hong, MD (1)  ·  Opeolu Adeoye, MD (1)  ·  Ron Waksman, MD (1)  ·  Zhenqiang Zhao, MD (1)  ·  Zhongming Qiu, MD (1)

Results publications

PMID 19332455, PMID 20670755, PMID 21300952, PMID 22373905, PMID 22645292, PMID 22995880, PMID 23416014, PMID 23537976, PMID 23995608, PMID 24016495, PMID 24093853, PMID 24562802, PMID 24607027, PMID 26957532, PMID 28052979, PMID 28089149, PMID 29895599, PMID 31976867, PMID 3201508, PMID 33296224, PMID 33297893, PMID 33427887, PMID 33430604, PMID 33518473, PMID 34329730, PMID 34838189, PMID 35105182, PMID 35130717, PMID 35224730, PMID 36711206, PMID 37256980, PMID 39231343, PMID 40123511, PMID 40824660, PMID 41071964

NIH funding

2009 (1), U01NS100699 (1)